2001 | 2002 | 2006 | April 2020 | August 2020 | February 2021 | |
---|---|---|---|---|---|---|
Hemoglobin 11.7–16 mg/dL | 12.5 | 12.8 | 12.8 | 11.5 | 12.7 | |
Platelet count (150–450 x103 cells/µL) |
142 199 |
244 |
172 149 131 |
38 43 55 |
174 | |
Protein C activity (70–130%) | 58% | 89% | ||||
Protein S activity (62–163%) | 60% | 55% | ||||
Protein S Ag free (70–160%) | 60% | |||||
ADAMTS13 activity | < 5%; 9% after 4 plasma exchanges | 5 | ||||
Imaging studies |
MRI: Subacute left basal ganglia infarct and acute left parietal lobe infarct Normal trans‐esophageal echocardiogram |
MRI: old left parietal, left caudate, and right frontal (subcortical/parasagittal) infarcts | MRI: acute infarction in the right superior frontal gyrus and subacute infarct at the right inferior frontal gyrus with hemorrhagic conversion |
CT: Acute right middle cerebral infarct |
||
Antithrombotic agent | Aspirin low‐dose | Warfarin INR target 2–3 | Enoxaparin to allow for testing protein C and S | Warfarin INR 1.8 on admission | Apixaban 5 mg twice daily | Apixaban 5 mg twice daily |
Other | Plasma exchange | Plasma infusions bi‐monthly |